WILLIAMS SONOMA INC·4

Jun 22, 7:04 PM ET

Finucane Anne A. 4

4 · WILLIAMS SONOMA INC · Filed Jun 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Williams‑Sonoma Director Anne Finucane Receives 1,028 RSUs

What Happened

  • Anne A. Finucane, a director of Williams‑Sonoma (WSM), had multiple derivative conversions and received a grant of restricted stock units (RSUs) on June 18, 2026. The filing shows conversions/exercises of 590 derivative shares (separate line items of 109, 162, 148 and 171 shares) and a grant/award of 1,028 RSUs. All transactions show a $0.00 per‑share price. Offsetting disposition entries for the same 590 derivative shares also appear in the filing. Net effect recorded in the filing: +1,028 contingent share units (RSUs/DSUs) to the reporting person.

Key Details

  • Transaction date: June 18, 2026; Form 4 filed June 22, 2026.
  • Transaction types: multiple conversions/exercises of derivative securities (code M) and a grant/award of RSUs (code A). All reported at $0.00 per share.
  • Specific counts: conversions/exercises acquired 109, 162, 148, 171 (total 590) and the award was 1,028 RSUs; matching dispositions of the 590 derivative shares are also listed. Net increase = 1,028 share‑equivalents.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes of note:
    • F1: Each RSU = a contingent right to one share of WSM common stock.
    • F2: The RSUs vest on the earlier of one year from grant or the day before the next regularly scheduled annual meeting.
    • F3: Each deferred stock unit (DSU) = a contingent right to one share.
    • F4: Deferred stock units were delivered to the reporting person on June 18, 2026, at the end of a previously elected deferral period.
  • Filing timing: the Form 4 was filed four days after the transaction date (filed 6/22 for 6/18). Form 4s are typically due within two business days of the transaction.

Context

  • These entries reflect equity compensation activity (awards, conversions/settlements), not an open‑market buy or sell. The $0.00 price is consistent with the vesting/conversion or delivery of RSUs/DSUs rather than a market purchase.
  • The presence of both acquisition and disposition lines for the same derivative amounts often appears when derivative securities are converted/settled and then delivered or redistributed as part of an award or deferral; footnote F4 confirms deferred units were delivered on June 18.
  • Such compensation entries are routine for directors and do not in themselves indicate a buy/sell market signal.

Insider Transaction Report

Form 4
Period: 2026-06-18
Transactions
  • Exercise/Conversion

    Common Stock

    2026-06-18+10910,198 total
  • Exercise/Conversion

    Common Stock

    2026-06-18+1629,770 total
  • Exercise/Conversion

    Common Stock

    2026-06-18+1489,918 total
  • Exercise/Conversion

    Common Stock

    2026-06-18+17110,089 total
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-06-18+1,0281,028 total
    Common Stock (1,028 underlying)
  • Exercise/Conversion

    Deferred Stock Units

    [F3][F4]
    2026-06-181620 total
    Common Stock (162 underlying)
  • Exercise/Conversion

    Deferred Stock Units

    [F3][F4]
    2026-06-181480 total
    Common Stock (148 underlying)
  • Exercise/Conversion

    Deferred Stock Units

    [F3][F4]
    2026-06-181710 total
    Common Stock (171 underlying)
  • Exercise/Conversion

    Deferred Stock Units

    [F3][F4]
    2026-06-181090 total
    Common Stock (109 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of WSM common stock.
  • [F2]The restricted stock units vest on the earlier of one year from the date of grant or the day before the next regularly scheduled annual meeting.
  • [F3]Each deferred stock unit represents a contingent right to receive one share of WSM common stock.
  • [F4]The deferred stock units were delivered to the reporting person on June 18, 2026, the end of the previously elected deferral period.
Signature
/s/ David R. King, Attorney-in-Fact for Anne Finucane|2026-06-22

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT